MEDICINE 润色咨询

medicine

出版年份：1922 年文章数：38863 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：6.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2022-03-26 Doctor'Curry

    Guidelines Checklist怎么弄？

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2024-03-25 X.Dawn 来自浙江省

    medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2021-02-11 14697d06m38(暂无昵称)

    刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2024-03-22 ms1000000549465605 来自重庆

    请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2024-03-19 ms1000000779917067 来自云南省

    有没有转投meidcine成功的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2024-01-29 苦行僧难上加难 来自江西省

    under review就是准备送外审了吗？

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2024-01-02 ms9000001415022170 来自吉林省

    sci怎么不更新medicine了

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2024-02-24 ms4000002086897803 来自北京

    偏重的研究方向：Meta;Meta分析
    经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2024-02-24 zll2020 来自四川省

    为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1206109, encodeId=ea7712061098d, content=Guidelines Checklist怎么弄？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8baa5416214, createdName=Doctor'Curry, createdTime=Sat Mar 26 14:17:49 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195248, encodeId=723c219524857, content=medicine返修以后还会拒稿吗，我是OA revise，现在已经with editor快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=448d5485741, createdName=X.Dawn, createdTime=Mon Mar 25 16:04:17 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=924138, encodeId=20249241380a, content=刚交了版面费，请问接下来是等Proof吗?通常从交版面费到online需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Thu Feb 11 00:12:38 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194651, encodeId=513d2194651d7, content=请问一下具体的审稿流程，我两个月还在Under Review是没戏了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7e59151108, createdName=ms1000000549465605, createdTime=Fri Mar 22 10:41:04 CST 2024, time=2024-03-22, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194062, encodeId=92a4219406282, content=有没有转投meidcine成功的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90598805369, createdName=ms1000000779917067, createdTime=Tue Mar 19 13:05:26 CST 2024, time=2024-03-19, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2184566, encodeId=afc621845665f, content=under review就是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=c6f15450000, createdName=苦行僧难上加难, createdTime=Mon Jan 29 09:25:17 CST 2024, time=2024-01-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2178761, encodeId=05ef21e8761c7, content=sci怎么不更新medicine了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09856574696, createdName=ms9000001415022170, createdTime=Tue Jan 02 11:51:58 CST 2024, time=2024-01-02, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2189052, encodeId=06d721890523c, content=偏重的研究方向：Meta;Meta分析<br>经验分享：审稿人两个，一个给的是小修，一个就是很刁钻，类似于拒了那样，然后编辑是让修改，也不知道接下来会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e6c6401028, createdName=ms4000002086897803, createdTime=Sat Feb 24 11:37:27 CST 2024, time=2024-02-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189043, encodeId=47b5218904343, content=为什么OA accept with minor revise之后，还要under review？以前不都是直接接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:16:06 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193712, encodeId=dfb02193e1269, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：幽门螺杆菌<br>经验分享：回顾性对照研究，6个审稿人，无尖锐问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/7e57bc019c3bdae0c212e820ef909f0b/d480353050a8590d6015e36951158eba.jpg, createdBy=72dc1951842, createdName=山大学医者, createdTime=Sun Mar 17 12:53:35 CST 2024, time=2024-03-17, status=1, ipAttribution=山东省)]
    2024-03-17 山大学医者 来自山东省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：幽门螺杆菌
    经验分享：回顾性对照研究，6个审稿人，无尖锐问题

    0

共500条页码: 2/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分